Xspray Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Xspray Pharma has a total shareholder equity of SEK693.4M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK765.3M and SEK71.9M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr166.30m |
| Equity | kr693.41m |
| Total liabilities | kr71.85m |
| Total assets | kr765.26m |
Recent financial health updates
We Think Xspray Pharma (STO:XSPRAY) Needs To Drive Business Growth Carefully
Feb 25
We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
May 11We Think Xspray Pharma (STO:XSPRAY) Can Afford To Drive Business Growth
Feb 01We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
Oct 26We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
Jun 20We're Hopeful That Xspray Pharma (STO:XSPRAY) Will Use Its Cash Wisely
Mar 19Recent updates
We Think Xspray Pharma (STO:XSPRAY) Needs To Drive Business Growth Carefully
Feb 25We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
May 11We Think Xspray Pharma (STO:XSPRAY) Can Afford To Drive Business Growth
Feb 01We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
Oct 26We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
Jun 20We're Hopeful That Xspray Pharma (STO:XSPRAY) Will Use Its Cash Wisely
Mar 19Do Institutions Own Xspray Pharma AB (publ) (STO:XSPRAY) Shares?
Feb 12Here's Why We're Watching Xspray Pharma's (STO:XSPRAY) Cash Burn Situation
Dec 04
Financial Position Analysis
Short Term Liabilities: XSPRAY's short term assets (SEK217.8M) exceed its short term liabilities (SEK39.9M).
Long Term Liabilities: XSPRAY's short term assets (SEK217.8M) exceed its long term liabilities (SEK31.9M).
Debt to Equity History and Analysis
Debt Level: XSPRAY is debt free.
Reducing Debt: XSPRAY has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XSPRAY has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: XSPRAY has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.2% each year